Cardio Diagnostics Holdings, Inc. (CDIO)
1.65
-0.04
(-2.37%)
USD |
NASDAQ |
Nov 19, 16:00
1.63
-0.02
(-1.21%)
After-Hours: 20:00
Cardio Diagnostics Holdings Gross Profit Margin (Quarterly) : -1.30K% for Sept. 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -1.30K% |
| June 30, 2026 | -824.1% |
| March 31, 2026 | -3.41K% |
| December 31, 2025 | -4.33K% |
| September 30, 2025 | -2.99K% |
| June 30, 2025 | -1.09K% |
| March 31, 2025 | -13.82K% |
| Date | Value |
|---|---|
| December 31, 2024 | -1.78K% |
| September 30, 2024 | -1.15K% |
| June 30, 2024 | -416.5% |
| March 31, 2024 | 47.17% |
| December 31, 2023 | -1.71K% |
| September 30, 2023 | 39.00% |
| June 30, 2023 | -182.4% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Tenax Therapeutics, Inc. | -- |
| Exicure, Inc. | -- |
| Century Therapeutics, Inc. | -- |
| Absci Corp. | -784.2% |
| Celularity, Inc. | 28.48% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -87.26% |
| Return on Assets | -69.17% |
| Return on Invested Capital | -82.12% |
| Profit Margin (Quarterly) | -48.12K% |
| Operating Margin (Quarterly) | -48.06K% |
| Return on Net Operating Assets | -361.0% |